To understand the underlying mechanism of this therapeutic intervention on NB tumour growth, we investigated gene expression in treated tumours from both Rosa26_Alkal2;Th-MYCN and Alk-F1178S;Th-MYCN relative to untreated controls. The gene discussed is ALK; the disease is neuroblastoma.